Agenda Links: Precon/Day 1 | Day 3
AGENDA: DAY II
THURSDAY, SEPTEMBER 14, 2017
7:30 am
Registration Commences
DAY II MORNING PLENARY SESSION
(With Simultaneous Chinese/English/Chinese Translation)
8:00 am
Co-chair Welcome and Introductions
8:15 am
Keynote: How to Cultivate a Compliance Culture in a Large Organization
Jean-Christophe Pointeau
Country Chair, Sanofi China; Board Member, JHL Biotech; Former President, China, Bristol-Myers Squibb, Shanghai, China
Country Chair, Sanofi China; Board Member, JHL Biotech; Former President, China, Bristol-Myers Squibb, Shanghai, China
9:00 am
The Chinese Anti-Unfair Competition Law, the Legal Basis for the Government Agencies’ Enforcement Actions against the Pharmaceutical Industry
Professor Huang Yong
Competition Law Center, University of International Business and Economics; Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, People’s Republic of China, Beijing, China
Competition Law Center, University of International Business and Economics; Executive Vice Chair, Expert Consultation Group, Anti-Monopoly Committee, State Council, People’s Republic of China, Beijing, China
Lei Li, LLM
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China (Moderator)
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China (Moderator)
9:30 am
Asia Pac Anti-Corruption Update Roundtable
Hwa Soo Chung, JD, MPA
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea
Chair, Health Practice Group, Kim and Chang, Seoul, South Korea
Lei Li, LLM
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA
Mini vandePol, LLB
Attorney and Chair, Global Compliance and Investigations Group, Baker McKenzie, Hong Kong
Attorney and Chair, Global Compliance and Investigations Group, Baker McKenzie, Hong Kong
Chris Fordham
Managing Partner, Asia Pacific, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong (Moderator)
Managing Partner, Asia Pacific, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong (Moderator)
10:45 am
Break
11:15 am
Managing Pharmaceutical and Medical Device Risk Across the Asia Pacific Region
Kent Kedl, MA
Senior Partner, Control Risks; Former Vice President and General Manager, Technomic Asia, Shanghai, China
Senior Partner, Control Risks; Former Vice President and General Manager, Technomic Asia, Shanghai, China
12:00 pm
Networking Luncheon
MINI SUMMITS BLOCK A: 1:30 pm – 2:45 pm
Mini Summit I: Chinese Anti-Corruption and Compliance Best Practices Roundtable
(Session in Chinese With Simultaneous Chinese/English Translation)
- The Impact China Regulatory Reforms on Compliance
- Incorporating the China Anti-Unfair Competition Amendment into a Compliance Program
1:30 pm
Introductions, Discussion and Q&A
Vanessa Han Jun
Head of Compliance, China, Novo Nordisk, Shanghai, China
Head of Compliance, China, Novo Nordisk, Shanghai, China
Christine Ng
Head, Ethics & Compliance Officer, Greater China, GSK, Shanghai, China
Head, Ethics & Compliance Officer, Greater China, GSK, Shanghai, China
Xi Zhang, PhD Law
Vice President & General Counsel Greater China, Bayer (China) Limited; Former General Counsel Asia, Celanese, Shanghai, China
Vice President & General Counsel Greater China, Bayer (China) Limited; Former General Counsel Asia, Celanese, Shanghai, China
Jonathan Shun Wah, PCLL
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong
Senior Director, China Investigations Team Lead, Pfizer, Hong Kong
Lei Li, LLM
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China (Co-moderator)
Partner, Sidley Austin; Former Third Secretary, Ministry of Commerce, People’s Republic of China, Beijing, China (Co-moderator)
Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP; Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China (Co-moderator)
Partner and Head, China Life Sciences Practice, Sidley Austin LLP; Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China (Co-moderator)
Mini Summit II: Asia Pac Medical Device Compliance Regulatory Developments and Burning Issues
1:30 pm
Introductions, Discussion and Q&A
M. Jason Brooke, JD
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance, and Investigations, Navigant; Former Board Member and General Counsel, Vasoptic Medical, Inc., Washington, DC, USA
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance, and Investigations, Navigant; Former Board Member and General Counsel, Vasoptic Medical, Inc., Washington, DC, USA
Campbell Clark, LLB, MJ
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited; Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore
Chief Ethics and Compliance Officer, Asia Pacific, Medtronic, Covidien Private Limited; Chair, Legal, Ethics and Compliance Committee, Asia Pacific Medical Technology Association (APACMed), Singapore
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc.; Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc.; Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore
Rhys Tee
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics; Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore (Moderator)
Director, Compliance and Privacy, ASPAC, Ortho Clinical Diagnostics; Former Compliance Director, Asia, Abbott Laboratories Pte. Ltd., Former Associate Director, Compliance (APAC), Allergan, Singapore (Moderator)
Mini Summit III: Global Data Privacy Update and the Impact to the Life Sciences Industry
1:30 pm
Introductions, Discussion and Q&A
Eric Carlson, JD
Partner, Covington & Burling LLP, Shanghai, China
Partner, Covington & Burling LLP, Shanghai, China
J. Mark Farrar, CPA, CFE, CFF
Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA (Moderator)
Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA (Moderator)
Mini Summit IV: The Evolution of Compliance Organizations
- Feb 2017 guidance from the US Department of Justice on Effective compliance programs has moved from 7 to 11 elements – what are these key additions?
- How is our function addressing the impact of technology? on the business? in our roles?
- How are we adding an emphasis on ethics?
- How are these changes impacting the compliance function? What about our roles as leaders and strategic advisors?
1:30 pm
Introductions, Discussion and Q&A
Karen Eryou
Head, Ethics and Compliance Programs, UCB Pharma; Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
Head, Ethics and Compliance Programs, UCB Pharma; Former Co-chair, Asia Pacific Pharma Compliance Congress, Brussels, Belgium
Jasmine Karimi, LLM
Senior Director & Counsel, APAC Illumina Inc., Immediate past President, Hong Kong Corporate Counsel Association, Singapore
Senior Director & Counsel, APAC Illumina Inc., Immediate past President, Hong Kong Corporate Counsel Association, Singapore
Geeta Thakerar
Legal AND Compliance consultancy professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore
Legal AND Compliance consultancy professional (Asia Pacific), Former Vice President and Associate General Counsel, Asia Pacific/Japan, GlaxoSmithKline plc, Singapore
Sabina Sudan, LLB, LLM
ECLS-Consults (Ethics/Compliance/Legal/ Sustainability), Legal/International Compliance and Risk Management Professional, Singapore and Delhi, India; Adjunct Professor, Nanyang Technological University, Singapore & National University Of Singapore; Admitted to practice in Arizona, New Delhi & New York; Former Compliance Officer Life Sciences Industry, Singapore and Delhi, India (Moderator)
ECLS-Consults (Ethics/Compliance/Legal/ Sustainability), Legal/International Compliance and Risk Management Professional, Singapore and Delhi, India; Adjunct Professor, Nanyang Technological University, Singapore & National University Of Singapore; Admitted to practice in Arizona, New Delhi & New York; Former Compliance Officer Life Sciences Industry, Singapore and Delhi, India (Moderator)
Mini Summit V: Transparency Reporting to Prevent Corruption Risk
- Transfer of Value in Life Science Industry
- Where are the Risk Areas?
- Overview on the Latest Transparency Reporting Requirements in Asia Pacific
- How to Effectively Gather Data from Different Sources for the Transfer of Value Engagement
- Best Practices that We Can Apply from US and EU to Asia Pacific
1:30 pm
Introductions, Discussion and Q&A
Myung Soon Chung, Esq.
Partner, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
Partner, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea
Yota Kikuchi
Director, Compliance Rules & Management, Japan Pharma Business Unit, Takeda Pharmaceuticals; Member, Code Compliance Committee, Japan Pharmaceutical Manufacturers Association; Member, IFPMA Ethics & Business Integrity Committee (eBIC), Tokyo, Japan
Director, Compliance Rules & Management, Japan Pharma Business Unit, Takeda Pharmaceuticals; Member, Code Compliance Committee, Japan Pharmaceutical Manufacturers Association; Member, IFPMA Ethics & Business Integrity Committee (eBIC), Tokyo, Japan
Yunjoh Lee, LLM
Attorney, Kim & Chang, Seoul, South Korea
Attorney, Kim & Chang, Seoul, South Korea
Clarissa Shen
China Head, Global Ethics & Business Integrity, Sanofi Group; Former Associate Compliance, Director, Eli Lilly China, Shanghai, China
China Head, Global Ethics & Business Integrity, Sanofi Group; Former Associate Compliance, Director, Eli Lilly China, Shanghai, China
Mike Zhao, MBA
Ethics and Compliance Lead, China, UCB; Former Compliance Manager, Johnson & Johnson, Shanghai, China
Ethics and Compliance Lead, China, UCB; Former Compliance Manager, Johnson & Johnson, Shanghai, China
Joyce Wong
Managing Director, Polaris Asia-Pacific; Former General Manager, Eli Lilly Asia Inc., Hong Kong (Moderator)
Managing Director, Polaris Asia-Pacific; Former General Manager, Eli Lilly Asia Inc., Hong Kong (Moderator)
2:45 pm
Transition Break
MINI SUMMITS BLOCK B: 3:00 pm – 4:15 pm
Mini Summit VI: How to Minimize Anti-Corruption Risks for Tier 2 and Tier 3 Cities and Mobile Offices
(Session in Chinese With Simultaneous Chinese/English Translation)
3:00 pm
Introductions, Panel Discussion and Q&A
Eric Carlson, JD
Partner, Covington & Burling LLP, Shanghai, China
Partner, Covington & Burling LLP, Shanghai, China
Vivian Chen, LLB
Head of Compliance, Alcon Laboratories China, A Novartis Division; Former Head of Ethics and Compliance, Greater China, Baxter Intl Inc., Beijing, China
Head of Compliance, Alcon Laboratories China, A Novartis Division; Former Head of Ethics and Compliance, Greater China, Baxter Intl Inc., Beijing, China
Chen Yang, LLB, LLM
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China
Partner and Head, China Life Sciences Practice, Sidley Austin LLP, Former Legislative Official, Bureau of Legislative Affairs, Chinese State Council, Beijing, China
Henry Yao, MA
Head of Compliance, Roche Diagnostics; Former Asia Compliance Leader, GE Energy Management, Shanghai, China
Head of Compliance, Roche Diagnostics; Former Asia Compliance Leader, GE Energy Management, Shanghai, China
Rachel B. Layburn, MBA
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China (Moderator)
Partner in Charge, Forensic and Investigations Practice, KPMG China, Beijing, China (Moderator)
Mini Summit VII: Compliance and Ethical Issues in Patient Support Programs and Activities with Patients and Patient Advocacy Organizations
3:00 pm
Introductions, Panel Discussion and Q&A
Mohit Grover
Executive Director, Risk Consulting, Deloitte; Former Regional Chief Information Officer, Astra Zeneca Asia Pacific, Singapore
Executive Director, Risk Consulting, Deloitte; Former Regional Chief Information Officer, Astra Zeneca Asia Pacific, Singapore
Ewa Holker
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
Legal & Compliance Director (APAC), Ferring Pharmaceuticals, Former Director, Legal & Compliance, Asia Pacific, Zimmer Biomet, Singapore
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA (Moderator)
Partner, Arnold & Porter LLP, Washington, DC, USA (Moderator)
Mini Summit VIII: Separation and Collaboration between Medical Education and Product Promotion
3:00 pm
Introductions, Panel Discussion and Q&A
Maija Burtmanis, LLB/BSc, LLM
Regional Compliance Director, Japan/Asia Pacific, Shire, Singapore
Regional Compliance Director, Japan/Asia Pacific, Shire, Singapore
Hwee Ping Chua, LLB, LLM
Associate Vice President, International Legal & Compliance, Asia Pacific, China & Japan, Merck, Former Regional Counsel, Asia Pacific, Bristol-Myers Squibb, Singapore
Associate Vice President, International Legal & Compliance, Asia Pacific, China & Japan, Merck, Former Regional Counsel, Asia Pacific, Bristol-Myers Squibb, Singapore
Christine Hu, LLM
Legal and Compliance Director, Medtronic Kanghui Orthopedics; Former Legal, Compliance & Government Affair Director, Zimmer, Beijing, China
Legal and Compliance Director, Medtronic Kanghui Orthopedics; Former Legal, Compliance & Government Affair Director, Zimmer, Beijing, China
Vivian Wu, LLB, LLM
Counsel, Fenxun Partners; Former Partner, Baker McKenzie, Beijing, China (Moderator)
Counsel, Fenxun Partners; Former Partner, Baker McKenzie, Beijing, China (Moderator)
Mini Summit IX: The Art of the Investigation: Planning, Executing and Completing Investigations
3:00 pm
Introductions, Panel Discussion and Q&A
Masood Ahmed
Vice President, Regional Compliance Officer, Asia and JPAC, Sanofi Group, Singapore
Vice President, Regional Compliance Officer, Asia and JPAC, Sanofi Group, Singapore
Calvin Chan, LLB, LLM
Partner, International Disputes and Investigations, Reed Smith, Singapore
Partner, International Disputes and Investigations, Reed Smith, Singapore
Praween Chantanakomes, JD
Senior Associate, Baker & McKenzie, Bangkok, Thailand
Senior Associate, Baker & McKenzie, Bangkok, Thailand
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, US Department of Justice, Washington, DC, USA
Winnie Ho
Partner, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong and Shanghai, China
Partner, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong and Shanghai, China
Mini Summit X: Organizational Justice: One of the Pillars of a Culture of Integrity
3:00 pm
Introductions, Panel Discussion and Q&A
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma; Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
APAC Ethics and Compliance Lead, UCB Pharma; Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Mike Zhao, MBA
Ethics and Compliance Lead, China, UCB; Former Compliance Manager, Johnson & Johnson, Shanghai, China
Ethics and Compliance Lead, China, UCB; Former Compliance Manager, Johnson & Johnson, Shanghai, China
Giuseppe Falbo
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division; Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore (Moderator)
Regional Compliance Director (APAC and Russia), Alcon, A Novartis Division; Former Business Practices Officer (Asia, Middle East, Africa, Latin America), Novartis International AG, Singapore (Moderator)
4:15 pm
Transition Break
MINI SUMMITS BLOCK C 4:30 pm – 5:45 pm
Mini Summit XI: Third Party (Distributor, Vendor, Alliance Partner, Government-related Associations, HCOs, etc.) Management, including Pre-evaluation, Due Diligence, Contracting, Monitoring and Payment
4:30 pm
Introductions, Panel Discussion and Q&A
Redentor Romero, JD
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International; Former Regional Compliance Officer, Teva Pharmaceuticals; Former Regional Legal Counsel, AstraZeneca, Singapore
Associate Director, Global Third Party Compliance Program, Takeda Pharmaceuticals International; Former Regional Compliance Officer, Teva Pharmaceuticals; Former Regional Legal Counsel, AstraZeneca, Singapore
Yuet Ming Tham, JD
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong
Carol Wu
Third Party Audit, Asia, Global Ethics & Compliance, GSK; Former Manager, Ethics & Compliance-China, Hospira; Former Senior Compliance Manager, AstraZeneca, Shanghai, China
Third Party Audit, Asia, Global Ethics & Compliance, GSK; Former Manager, Ethics & Compliance-China, Hospira; Former Senior Compliance Manager, AstraZeneca, Shanghai, China
Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA (Moderator)
President and Founder, Polaris, New York, NY, USA (Moderator)
Mini Summit XII: When Will You Deploy Robot(s) in your Compliance Team?
- What is Artificial Intelligence?
- Ideas to Apply Artificial Intelligence to Compliance Analytics/Operations
- What the Future May Look Like
4:30 pm
Introductions, Panel Discussion and Q&A
Maria “Maru” Quindimil, MBA
APAC Ethics and Compliance Lead, UCB Pharma; Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
APAC Ethics and Compliance Lead, UCB Pharma; Former Executive Director, Regional Compliance Officer, Asia Pacific and India, Merck Sharp and Dohme (Asia Ltd.), Shanghai, China
Junjie Yao, PhD
Associate Professor, School of computer science and software engineering, Advanced Institute of Data Analysis, East China Normal University, Shanghai, China
Associate Professor, School of computer science and software engineering, Advanced Institute of Data Analysis, East China Normal University, Shanghai, China
Chi Chen
Forensic Technology Partner, Ernst & Young LLP, Shanghai, China (Moderator)
Forensic Technology Partner, Ernst & Young LLP, Shanghai, China (Moderator)
Mini Summit XIII: Korean Anti-Corruption and Compliance Best Practices Roundtable
4:30 pm
Introductions, Panel Discussion and Q&A
Brian Caster, JD
APAC Regional Compliance Investigations Lead, Pfizer, Tokyo, Japan
Steven Chon, MA
Director, Fraud Investigation & Dispute Services, Ernst & Young LLP, Hong Kong
Yunjoh Lee, LLM
Attorney, Kim & Chang, Seoul, South Korea
Kyungsun Kyle Choi
Senior Foreign Legal Consultant, Kim & Chang Law Firm, Seoul, South Korea (Moderator)
Mini Summit XIV: Fraud Trends in Asia Pacific and How Companies are Dealing with Them
4:30 pm
Introductions, Panel Discussion and Q&A
Ronald Goon
Senior Director, Business Practices & Compliance, Johnson & Johnson, Singapore
John Tan, JD
Partner, ReedSmith; Former China Regional Compliance Director, Pfizer, Shanghai, China
Stacy Chai
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Singapore (Moderator)
5:45 pm
Adjournment and Networking Reception
Agenda Links: Precon/Day 1 | Day 3